GLP Watchdog

Gala vs Oak

Neither Gala nor Oak has an FDA warning letter on record. On compounded tirzepatide injection, Gala costs $1,452 less a year at standing rates: $179 a month against $300 a month at Oak. It is one of three products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Gala / Oak

Gala logo

Gala

8.5/10

Oak logo

Oak

7.2/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$100/moBrand-name semaglutide pill, billed every 4 weeks
States
All 50 states
48 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Gala
Visit Oak

Both Gala and Oak are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Gala 8.5, Oak 7.2). How we are paid

What the record shows

  1. 01

    Neither Gala nor Oak has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded tirzepatide injection, Gala costs $1,452 less a year at standing rates: $179 a month against $300 a month at Oak. It is one of three products the two sell at comparable terms.

  4. 04

    Only Oak lists a price for brand-name tirzepatide pen, compounded oral semaglutide and brand-name semaglutide pill.

  5. 05

    Gala covers two states Oak does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gala

Oak

Compounded semaglutide injection

$179/moLower

$2,148 a year

$250/mo

$3,000 a year

Compounded tirzepatide injection

$179/moLower

$2,148 a year

$300/mo

$3,600 a year

Brand-name semaglutide pen

$1,299/moLower

$15,588 a year

$1,250/mo

$16,250 a year, 13 charges

Brand-name tirzepatide pen
Not sold or not priced

$1,200/mo

$15,600 a year, 13 charges

Compounded oral semaglutide
Not sold or not priced

$260/mo

$3,380 a year, 13 charges

Brand-name semaglutide pill
Not sold or not priced

$100/mo

$1,300 a year, 13 charges

Price includes
Medication, clinician visits, shipping
Medication, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
None (3-, 6- and 12-month plans optional)
Refunds
No refund on cancellation; full refund only if the medical provider disqualifies you
No refunds once a provider approves the order
Early-exit fee
Not stated
Yes

Read off each seller’s own pages. Gala: October 17, 2026. Oak: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gala

8.5/10
  • $852 a year less on compounded semaglutide injection
  • $1,452 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy
Visit Gala

The case for Oak

7.2/10
  • Sells brand-name tirzepatide pen and compounded oral semaglutide, which Gala does not price
  • Names no compounding pharmacy
Visit Oak

Scores

Gala 8.5 · Oak 7.2 out of 10. Six weighted parts.

Value25%

7.9A
vs
B
3.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
7.5

Accessibility10%

10.0A
vs
B
9.7

Support10%

7.0A
vs
B
6.0

The score is the same formula for every seller. Payment does not enter it. Method

Gala vs Oak: questions

Neither Gala nor Oak has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Gala, by $852 a year at standing rates. Gala: $179 a month, about $2,148 a year. Oak: $250 a month, about $3,000 a year.
Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you. Oak states you can cancel at any time; refunds: no refunds once a provider approves the order.
Both Gala and Oak are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Gala 8.5, Oak 7.2).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks